-+ 0.00%
-+ 0.00%
-+ 0.00%

Results: Auxly Cannabis Group Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St·11/15/2026 14:42:56
Listen to the news

Auxly Cannabis Group Inc. (TSE:XLY) just released its third-quarter report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 7.3% to hit CA$49m. Auxly Cannabis Group also reported a statutory profit of CA$0.12, which was an impressive 33% above what the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Auxly Cannabis Group after the latest results.

earnings-and-revenue-growth
TSX:XLY Earnings and Revenue Growth November 15th 2026

Taking into account the latest results, the current consensus from Auxly Cannabis Group's dual analysts is for revenues of CA$202.9m in 2027. This would reflect a meaningful 16% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to bounce 44% to CA$0.36. Yet prior to the latest earnings, the analysts had been anticipated revenues of CA$197.6m and earnings per share (EPS) of CA$0.19 in 2027. There's been a pretty noticeable increase in sentiment, with the analysts upgrading revenues and making a very substantial lift in earnings per share in particular.

Check out our latest analysis for Auxly Cannabis Group

It will come as no surprise to learn that the analysts have increased their price target for Auxly Cannabis Group 5.6% to CA$4.75on the back of these upgrades.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2027 brings more of the same, according to the analysts, with revenue forecast to display 12% growth on an annualised basis. That is in line with its 15% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 9.6% per year. So although Auxly Cannabis Group is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Auxly Cannabis Group's earnings potential next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2028, which can be seen for free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Auxly Cannabis Group , and understanding this should be part of your investment process.